Clene Inc. (CLNN) vs Xilio Therapeutics, Inc. (XLO)
Clene Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Clene Inc. and Xilio Therapeutics, Inc. are of similar size ($59.8M and $59.2M). Xilio Therapeutics, Inc. grew revenue faster over the last twelve months: 327.3% against −31.1%. Xilio Therapeutics, Inc. has the higher net margin (−34.1% vs −20,059.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Xilio Therapeutics, Inc. leads on 11 and Clene Inc. on 4.
Valuation
Profitability
| Metric | CLNN | XLO | Biotechnology median |
|---|---|---|---|
| Gross margin | 70.05% | 100.00% | 65.16% |
| Operating margin | (10,431.98%) | (48.94%) | 0.00% |
| Net margin | (20,059.90%) | (34.06%) | 0.00% |
| Free cash flow margin | (8,095.43%) | (95.59%) | 0.00% |
| Return on equity | 237.15% | (55.03%) | (57.72%) |
| Return on assets | (174.99%) | (15.16%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack